Marielle Chiron

Title: Marielle Chiron: Innovator in Natural Killer Cell Engagers

Introduction

Marielle Chiron is a prominent inventor based in Paris, France. She has made significant contributions to the field of biotechnology, particularly in the development of multifunctional binding proteins. With a total of 3 patents, her work focuses on innovative solutions for treating proliferative disorders.

Latest Patents

Chiron's latest patents include groundbreaking research on natural killer (NK) cell engagers. One of her patents describes multifunctional binding proteins that comprise a first and a second antigen binding domain (ABD). The first ABD specifically binds to human BCMA, while the second ABD binds to human NKp46. This invention aims to create proteins that can be used in the treatment or prevention of multiple myeloma (MM). Another patent focuses on multifunctional NK cell engagers that bind to NKp46 and CD123, targeting acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).

Career Highlights

Throughout her career, Marielle Chiron has worked with notable companies in the pharmaceutical industry, including Aventis Pharma and Innate Pharma. Her expertise in the field has allowed her to contribute to significant advancements in cancer treatment.

Collaborations

Chiron has collaborated with esteemed colleagues such as Angela Virone-Oddos and Laurent Gauthier. These partnerships have further enhanced her research and development efforts in the biotechnology sector.

Conclusion

Marielle Chiron's innovative work in the field of natural killer cell engagers showcases her dedication to advancing medical science. Her patents reflect her commitment to finding effective treatments for serious health conditions.